Posted by Michael Wonder on 14 Sep 2020
EMA publishes agenda for 14-17 September CHMP meeting
14 September 2020 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Bupivacine
- Meningococcal Groups A, C, W135 & Y conjugate vaccine
- Pegfilgrastim
- Obiltoxaximab
- Melphalan
- Rivaroxaban
- Influenza vaccine (quadrivalent)
